EducationPhD University of Oslo (Norway), 1996 (Epidemiology)
MS University of Zagreb (Yugoslavia), 1991 (Biostatistics)
MD University of Zagreb (Yugoslavia), 1987 (Internal Medicine)
Contact Infoemail: firstname.lastname@example.org
4333 Brooklyn Ave NE, Rm 14-315
Seattle, WA 98195-9455
campus box: 359455
Dr. Kopjar is an internationally recognized scholar and expert in biostatistics and clinical epidemiology. He serves as an author/co-author on over 500 published original articles, reviews, technical reports and abstracts. His research interests include: spinal cord injury and diseases, neurosurgery, orthopaedics, preventive medicine and healthcare reform. Dr. Kopjar has been actively participating in the design, management and analysis of clinical trials and medical research for more than 30 years. He is a frequent contributor to such peer-reviewed publications as the Journal of Neurosurgery, the American Journal of Public Health, Spine and the Journal of Bone and Joint Surgery. In the 1990’s he served as the research director for the Norwegian Foundation for Health Services Research and department head of the Section for Preventive Medicine at the Norwegian National Institute of Public Health. As a consultant, he works closely with the leading global pharmaceutical, medical device and venture capital firms in regards to determining the efficacy, safety and investment value of medical technologies. Dr. Kopjar is active in a variety of research organizations including: AOSpine North America, The North American Spine Society (NASS), Cervical Spine Research Society (CSRS) and the International Scholarly Research Network (ISRN). He serves on the editorial board and as a reviewer for a number of academic journals and he is the current director of the Executive Master of Public Health program at the University of Washington. Dr. Kopjar holds the title of Distinguished Professor at Chongqing University in China. In the 2000's he held the title of Adviser to the Minister of Health for two European governments. He is a past recipient of the prestigious John M. Eisenberg Article-of-the-Year award.
Arnold PM, Sasso RC, Janssen ME, Fehlings MG, Smucker JD, Vaccaro AR, Heary RF, Patel AI, Goulet B, Kalfas IH, Kopjar B. Efficacy of i-Factor Bone Graft versus Autograft in Anterior Cervical Discectomy and Fusion: Results of the Prospective Randomized Single-blinded Food and Drug Administration Investigational Device Exemption Study. Spine (Phila Pa 1976). 2016 Jan 27. [Epub ahead of print] PMID: 26825787
Fehlings MG, Nater A, Tetreault L, Kopjar B, Arnold P, Dekutoski M, Finkelstein J, Fisher C, France J, Gokaslan Z, Massicotte E, Rhines L, Rose P, Sahgal A, Schuster J, Vaccaro A. Survival and Clinical Outcomes in Surgically Treated Patients With Metastatic Epidural Spinal Cord Compression: Results of the Prospective Multicenter AOSpine Study. J Clin Oncol. 2016 Jan 20;34(3):268-76. doi: 10.1200/JCO.2015.61.9338. Epub 2015 Nov 23. PMID: 26598751
Gornet MF, Schranck FW, Copay AG, Kopjar B. The Effect of Workers' Compensation Status on Outcomes of Cervical Disc Arthroplasty: A Prospective, Comparative, Observational Study. J Bone Joint Surg Am. 2016 Jan 20;98(2):93-9. doi: 10.2106/JBJS.O.00324. PMID: 26791029
Fehlings MG, Nakashima H, Nagoshi N, Chow DS, Grossman RG, Kopjar B. Rationale, design and critical end points for the Riluzole in Acute Spinal Cord Injury Study (RISCIS): a randomized, double-blinded, placebo-controlled parallel multi-center trial. Spinal Cord. 2016 Jan;54(1):8-15. doi: 10.1038/sc.2015.95. Epub 2015 Jun 23. PMID: 26099215
PI: Kopjar Dates: 4/1/2011 - 12/31/2016
The aim of this study is to evaluate efficacy and safety of riluzole in the treatment of patients with acute spinal cord injury (SCI).
Efficacy of Riluzole in Surgical Treatment for Cervical Spondylotic Myelopathy (CSM-Protect)
Study of the efficacy of Riluzole in patients with cervical spondylotic myelopathy undergoing surgical treatment. A randomized, double-blind, placebo-controlled multi-center study